National Taiwan University Hospital
Taipei, 100, Taiwan
NCT Number: NCT07696442
The goal of this clinical trial is to learn if a music-based intervention works to improve sleep and health in children with epilepsy and their parents. The main question it aims to answer is: Does the music-based intervention improve sleep and health for both the children and their parents?
Trial opening soon.
Get Notified18 month–9 year
All sexes
Interventional
Not applicable
Taipei, 100, Taiwan
Researchers will compare two different music modules, an experimental module and a control module, to determine if the experimental module yields better outcomes.
Participants will:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will listen to a standardized nighttime music piece within approximately 30 minutes before their habitual bedtime and a daytime intervention music piece upon waking each day for 6 months.
Participants will listen to a standardized nighttime music piece within approximately 30 minutes before their habitual bedtime and a daytime placebo music piece upon waking each day for 6 months.
Time frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
Sleep efficiency, measured objectively using actigraphy, is a key indicator of sleep quality. It is calculated as the ratio of total nighttime sleep time to time in bed, multiplied by 100%.
Time frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
Total Nighttime Sleep is defined as the total duration (minutes) scored as sleep within the nocturnal rest interval.
Time frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
Daily 24-hour sleep duration is defined as total nighttime sleep plus nap duration.
Time frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
Sleep onset latency is defined as the duration (minutes) from diary-reported bedtime to actigraphy-derived sleep onset.
Time frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
Wake after sleep onset (WASO) is defined as the duration (minutes) scored as wake between sleep onset and final awakening.
Time frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
The Children's Sleep Habits Questionnaire (CSHQ) is a 33-item parent-report questionnaire that assesses sleep behaviors in children. Items are rated on a 3-point scale, with higher scores indicating more sleep problems.
Time frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
The Child Behavior Checklist (CBCL) is a 120-item parent-report instrument used to assess behavioral and emotional problems in children. Parents rate each item on a 3-point Likert scale, with higher scores indicating a greater presence of behavioral and emotional problems.
Time frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report questionnaire that assesses parents' overall sleep quality. The 19 items are combined into seven component scores (0-3), which are summed to generate a global score ranging from 0 to 21. Higher scores indicate poorer sleep quality, with a global score >5 suggesting significant sleep difficulties.
Time frame: Baseline, 2 weeks, 3 months, and 6 months after randomization
The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report questionnaire that assesses parents' depressive symptoms. Items are rated on a 4-point Likert scale (0-3), with higher scores indicating more severe depressive symptoms.
Contact information is provided by the study sponsor or research team.
National Taiwan University Hospital
Other
Music-Based Intervention for Pediatric Epilepsy
Acronym: SMART-2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06546410
Brain Diseases, Central Nervous System Diseases
Liverpool, United Kingdom
View Trial DetailsNCT06376279
Brain Diseases, Central Nervous System Diseases
View Trial DetailsNCT04770337
Brain Diseases, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT06585605
Ataxia, Brain Diseases
Boston, Massachusetts, United States
View Trial Details